BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Durmus T, Schilling R, Doeblin P, Huppertz A, Hamm B, Taupitz M, Wagner M. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine. Invest Radiol 2012;47:183-8. [PMID: 22183078 DOI: 10.1097/RLI.0b013e318236e354] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Domnin P, Arkhipova A, Petrov S, Sysolyatina E, Parfenov V, Karalkin P, Mukhachev A, Gusarov A, Moisenovich M, Khesuani Y, Ermolaeva S. An In Vitro Model of Nonattached Biofilm-Like Bacterial Aggregates Based on Magnetic Levitation. Appl Environ Microbiol 2020;86:e01074-20. [PMID: 32680859 DOI: 10.1128/AEM.01074-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wildgruber M, Stadlbauer T, Rasper M, Hapfelmeier A, Zelger O, Eckstein HH, Halle M, Rummeny EJ, Huber AM. Single-dose gadobutrol in comparison with single-dose gadobenate dimeglumine for magnetic resonance imaging of chronic myocardial infarction at 3 T. Invest Radiol 2014;49:728-34. [PMID: 24872002 DOI: 10.1097/RLI.0000000000000076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rudolph A, Messroghli D, von Knobelsdorff-Brenkenhoff F, Traber J, Schüler J, Wassmuth R, Schulz-Menger J. Prospective, randomized comparison of gadopentetate and gadobutrol to assess chronic myocardial infarction applying cardiovascular magnetic resonance. BMC Med Imaging 2015;15:55. [PMID: 26576944 DOI: 10.1186/s12880-015-0099-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
4 Zhao SH, Chen YY, Yun H, Fu CX, Zeng MS, Ge MY, Jin H. Three-Dimensional Free-Breathing Whole-Heart Coronary Magnetic Resonance Angiography at 1.5 T: Gadobutrol-Enhanced Gradient-Echo Acquisition Sequence Versus Non-Contrast-Enhanced Steady-State Free Precession Sequence. J Comput Assist Tomogr 2019;43:919-25. [PMID: 31738205 DOI: 10.1097/RCT.0000000000000933] [Reference Citation Analysis]
5 Kim YK, Park EA, Lee W, Kim SY, Chung JW. Late gadolinium enhancement magnetic resonance imaging for the assessment of myocardial infarction: comparison of image quality between single and double doses of contrast agents. Int J Cardiovasc Imaging 2014;30 Suppl 2:129-35. [PMID: 25086702 DOI: 10.1007/s10554-014-0505-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
6 D'Angelo T, Grigoratos C, Mazziotti S, Bratis K, Pathan F, Blandino A, Elen E, Puntmann VO, Nagel E. High-throughput gadobutrol-enhanced CMR: a time and dose optimization study. J Cardiovasc Magn Reson. 2017;19:83. [PMID: 29110679 DOI: 10.1186/s12968-017-0400-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
7 Monti CB, Codari M, Cozzi A, Alì M, Saggiante L, Sardanelli F, Secchi F. Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction. Eur Radiol Exp 2020;4:21. [PMID: 32242266 DOI: 10.1186/s41747-020-00149-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Loehr JA, Stinnett GR, Hernández-Rivera M, Roten WT, Wilson LJ, Pautler RG, Rodney GG. Eliminating Nox2 reactive oxygen species production protects dystrophic skeletal muscle from pathological calcium influx assessed in vivo by manganese-enhanced magnetic resonance imaging. J Physiol 2016;594:6395-405. [PMID: 27555555 DOI: 10.1113/JP272907] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Bulluck H, Hammond-Haley M, Weinmann S, Martinez-Macias R, Hausenloy DJ. Myocardial Infarct Size by CMR in Clinical Cardioprotection Studies: Insights From Randomized Controlled Trials. JACC Cardiovasc Imaging 2017;10:230-40. [PMID: 28279370 DOI: 10.1016/j.jcmg.2017.01.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]